http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103845727-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 |
| filingDate | 2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103845727-B |
| titleOfInvention | Nasal administration composition of recombination human ciliary neurotrophy factor and preparation method thereof |
| abstract | The invention discloses nasal administration composition of a kind of recombination human ciliary neurotrophy factor and preparation method thereof, the nasal administration composition of described recombination human ciliary neurotrophy factor, by weight percentage, contain: recombination human ciliary neurotrophy factor 0 ~ 1%, albumen infiltration auxiliary material 0 ~ 20%, buffer composition (pH5 ~ 9) 0 ~ 5%, inorganic salt 0 ~ 5%, water 0 ~ 99%.The invention has the advantages that: control body weight effect is suitable with drug administration by injection, and not easily produces antibody. |
| priorityDate | 2013-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.